Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

BACKGROUND Chagas disease, caused by Trypanosoma cruzi, affects nearly six million people worldwide. Various serological tests have been developed for its diagnosis. OBJECTIVE Examine the performance of a set of commercial immunological assays in relation to the geographical origin of the patient...

Full description

Bibliographic Details
Main Authors: Amadeo Sáez-Alquezar, Angela Cristina Verissimo Junqueira, Andressa da Matta Durans, André Valpassos Guimarães, José Abol Corrêa, José Borges-Pereira, Patrícia Lago Zauza, Pedro Hernan Cabello, Pedro Albajar-Viñas, David William Provance Jr, José Rodrigues Coura
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2021-05-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Trypanosoma cruzi
human Chagas disease
serological diagnostic test
immunoassays
International Biological Reference Standards
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100310&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100310&tlng=en

Similar Items